11,051 Shares in Procter & Gamble Company (The) $PG Purchased by Quent Long Short Global Small Cap Fund LP

Key Points

• Quent Long Short Global Small Cap Fund LP opened a new position of 11,051 P&G shares in Q4, worth about $1.584 million; institutional investors now own 65.77% of the company.
• P&G raised its quarterly dividend to $1.0885 (annualized $4.35, ~3.0% yield) payable May 15, and recent results showed EPS of $1.88 (beat by $0.02) while revenue of $22.21B slightly missed expectations, up 1.5% year‑over‑year.
• Insider selling and analyst target cuts are notable headwinds — insiders sold ~252,715 shares (~$41M) over the last three months, and several firms have trimmed price targets (consensus target ~$162.37, "Moderate Buy").

Quent Long Short Global Small Cap Fund LP bought a new position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 11,051 shares of the company's stock, valued at approximately $1,584,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC acquired a new stake in Procter & Gamble during the 3rd quarter worth $25,000. Maseco LLP acquired a new stake in Procter & Gamble during the 4th quarter worth $28,000. Saranac Partners Ltd acquired a new stake in Procter & Gamble during the 3rd quarter worth $30,000. Corundum Trust Company INC acquired a new stake in Procter & Gamble during the 3rd quarter worth $32,000. Finally, Caitlin John LLC acquired a new position in shares of Procter & Gamble during the 3rd quarter worth approximately $34,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Trading Up 2.0%

PG opened at $145.77 on Friday. Procter & Gamble Company has a one year low of $137.62 and a one year high of $170.99. The stock has a market capitalization of $338.77 billion, a PE ratio of 21.60, a P/E/G ratio of 5.50 and a beta of 0.41. The business's 50 day moving average price is $150.56 and its 200 day moving average price is $148.72. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Friday, January 23rd. The company reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The firm had revenue of $22.21 billion for the quarter, compared to analysts' expectations of $22.36 billion. During the same period in the prior year, the firm posted $1.88 earnings per share. The firm's quarterly revenue was up 1.5% on a year-over-year basis. As a group, equities research analysts expect that Procter & Gamble Company will post 6.96 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be given a $1.0885 dividend. The ex-dividend date of this dividend is Friday, April 24th. This is an increase from Procter & Gamble's previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. Procter & Gamble's dividend payout ratio is currently 62.67%.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G was named #1 in the Household Products category on Fortune’s 2026 “America’s Most Innovative Companies” list — a credibility boost for the company’s product-led growth story and a positive signal for top‑line resilience. Fortune recognition
• Positive Sentiment: Febreze unveiled a new in‑home product (Febreze TRASH) aimed at recurring, high‑frequency use — a tangible example of innovation that can help support market share and recurring sales in home care. Febreze TRASH launch
• Positive Sentiment: Analyst commentary and modelers (TipRanks, others) highlight that PG’s valuation looks more attractive heading into earnings, which can attract buyers if results meet or beat estimates. TipRanks valuation note
• Positive Sentiment: Dividend/total‑return narratives continue to support long‑term demand for PG shares (featured in lists highlighting income stocks), which can underpin steadier flows amid market volatility. Dividend stock feature
• Neutral Sentiment: Multiple previews note analysts expect modest year‑over‑year sales and EPS growth for Q3 (Zacks/consensus revenue ~ $20.6B) — the upcoming print is the main near‑term catalyst; outcome will likely dictate the next directional move. Earnings preview
• Neutral Sentiment: Benzinga and Yahoo previews reiterate that the company’s results will be watched for consumer spending trends — useful context but not new company‑specific news. Benzinga preview
• Neutral Sentiment: P&G management publicly rejected a low‑ball mini‑tender offer — procedural noise that briefly attracts attention but has minimal business impact. Mini‑tender discussion
• Neutral Sentiment: Smaller items (industry features, licensing mentions) surface in niche outlets; they add color but are unlikely to move shares materially near term. Minor licensing note
• Negative Sentiment: Morgan Stanley trimmed its price target to $166 (from $175) while keeping an overweight rating — a lower target can reduce upside expectations even if the firm remains constructive. Morgan Stanley PT cut
• Negative Sentiment: BNP Paribas Exane lowered its target to $165 (from $172) while retaining an outperform call — another downward tweak that trims consensus upside. BNP Paribas PT cut
• Negative Sentiment: Additional firms (BofA, Jefferies) have nudged targets lower in recent weeks; those combined analyst trims have contributed to intraday weakness reported after downgrades. Investors should view these as headwinds that could cap rally if earnings disappoint. BofA / Jefferies notes

Insider Buying and Selling

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,827 shares of the company's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total value of $2,056,296.37. Following the transaction, the insider owned 12,639 shares of the company's stock, valued at $2,026,158.09. This represents a 50.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the company's stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the transaction, the insider directly owned 44,735 shares in the company, valued at $7,259,595.80. The trade was a 25.32% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 252,715 shares of company stock valued at $40,966,904 over the last three months. Company insiders own 0.20% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Barclays lowered their target price on Procter & Gamble from $155.00 to $146.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 14th. The Goldman Sachs Group lowered their target price on Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating on the stock in a report on Wednesday, April 8th. Raymond James Financial lowered their target price on Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating on the stock in a report on Tuesday, April 14th. TD Cowen lowered their target price on Procter & Gamble from $156.00 to $142.00 and set a "hold" rating on the stock in a report on Wednesday, April 1st. Finally, Jefferies Financial Group lowered their price target on shares of Procter & Gamble from $179.00 to $175.00 and set a "buy" rating on the stock in a research report on Monday. Twelve research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $162.37.

Procter & Gamble Profile

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.